Transforming rectal therapies for ulcerative colitis using novel hydrogel formulation

Ravi is the co-founder and CEO of Intact Therapeuetics, a venture-backed biopharma startup spun out of Stanford University, focused on targeted therapies for diseases of the gastrointestinal tract. Prior to Intact, he led marketing and medical affairs at Transcend Medical, working on a novel minimally invasive glaucoma implant, up until its sale to Alcon/Novartis for a total deal value of >$500 M. He began his career working in research and development for Guidant Corporation, developing best-in-class technologies for cardiac and vascular surgery. He received a BS in Mechanical Engineering, an MS in Management Science & Engineering, and fellowship training in Biodesign (biomedical innovation), all from Stanford University.